These findings illuminate the roles of STI1 in regulating the accumulation and toxicity of misfolded α-synuclein in vivo and suggest that targeting the interaction of STI1 with α-synuclein may modulate disease progression in synucleinopathies. Here, STIP1 is linked to synucleinopathy.